Apolipoprotein A-I glycation by Glucose and Reactive Aldehydes Alters Phospholipid Affinity but Not Cholesterol Export from Lipid-Laden Macrophages

Advanced Glycation in macrophages induces intracellular accumulation of 7-ketocholesterol and total sterols by decreasing the expression of ABCA-1 and ABCG-1

(2011) Rodrigo T Iborra et al.   Lipids in Health and Disease

Modified apolipoprotein (apo) A-I by artificial sweetener causes severe premature cellular senescence and atherosclerosis with impairment of functional and structural properties of apoA-I in lipid-free and lipid-bound state

(2011) Wookju Jang et al.   MOLECULES AND CELLS

Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I

(2010) Estelle Nobécourt et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence

(2010) Ki-Hoon Park et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Oxidative Stress and Diabetic Complications

(2010) Ferdinando Giacco et al.   CIRCULATION RESEARCH

Modifying Apolipoprotein A-I by Malondialdehyde, but Not by an Array of Other Reactive Carbonyls, Blocks Cholesterol Efflux by the ABCA1 Pathway

(2010) Baohai Shao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Metformin restores impaired HDL-mediated cholesterol efflux due to glycation

(2009) Kota Matsuki et al.   ATHEROSCLEROSIS